Sterile Manufacturing Services Fee. 9.1 Te Whatu Ora will pay the Provider a Sterile Manufacturing Services Fee for each Pharmaceutical that the Provider Dispenses in accordance with this Agreement.
9.2 The Sterile Manufacturing Services Fee is calculated as follows: R = ((Sc + (Sc x M) + PF + (HF x HFM)) x GST) – CoP where: R = the Sterile Manufacturing Services Fee that Te Whatu Ora will pay the Provider (if R is a positive number) Sc = the GST exclusive subsidy specified for the Pharmaceutical in the Pharmaceutical Schedule on the date of Dispensing M = a margin towards the procurement and stockholding costs for the Pharmaceutical, which is: (a) 0.03 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is less than $150.00; and (b) 0.04 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is $150.00 or more PF = the Per Pack Fee HF = the Handling Fee for the Pharmaceutical, which is $1.13 HFM = the Handling Fee Multiplier for the Pharmaceutical, which is 26.50 GST = 1.15 (or such other amount as correctly reflects the GST rate on the date of Dispensing) CoP = the Co-payment that the Provider may charge the Service User (if any). SCHEDULE 3A.4 CLOZAPINE SERVICES (MONITORED THERAPY MEDICINE SERVICES)
1. Background and service objectives
Sterile Manufacturing Services Fee. 9.1 The DHB will pay the Provider a Sterile Manufacturing Services Fee for each Pharmaceutical that the Provider Dispenses in accordance with this Agreement.
9.2 The Sterile Manufacturing Services Fee is calculated as follows: R = ((Sc + (Sc x M) + PF + (HF x HFM)) x GST) – CoP where: R = the Sterile Manufacturing Services Fee that the DHB will pay the Provider (if R is a positive number) Sc = the GST exclusive subsidy specified for the Pharmaceutical in the Pharmaceutical Schedule on the date of Dispensing M = a margin towards the procurement and stockholding costs for the Pharmaceutical, which is: (a) 0.03 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is less than $150.00; and (b) 0.04 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is $150.00 or more PF = the Per Pack Fee HF = the Handling Fee for the Pharmaceutical, which is $1.01 HFM = the Handling Fee Multiplier for the Pharmaceutical, which is 26.50 GST = 1.15 (or such other amount as correctly reflects the GST rate on the date of Dispensing) CoP = the Co-payment that the Provider may charge the Service User (if any).
1. Background and service objectives
1.1 This Service Schedule relates to the provision of clozapine, blood test monitoring, and recording of Dispensing of clozapine.
1.2 Prescribers and providers will play appropriate roles in the safe provision of clozapine.
1.3 The purpose of Clozapine Services is to ensure that providers are able to support Service Users taking clozapine appropriately, in a way that reflects best practice for the management of this Pharmaceutical.
Sterile Manufacturing Services Fee. 9.1 The DHB will pay the Provider a Sterile Manufacturing Services Fee for each Pharmaceutical that the Provider Supplies in accordance with this Schedule.
9.2 The Sterile Manufacturing Services Fee is calculated as follows: R = ((Sc + (Sc x M) + PF + (HF x HFM)) x GST) – CoP where: R = the Sterile Manufacturing Services Fee that the DHB will pay the Provider (if R is a positive number) Sc = the GST exclusive subsidy specified for the Pharmaceutical in the Pharmaceutical Schedule as at the date of Supply M = a margin towards the procurement and stockholding costs for the Pharmaceutical, which is: (a) 0.03 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is less than $150.00; and (b) 0.04 if the Pharmaceutical Schedule Pack Subsidy for the Pharmaceutical is $150.00 or more PF = the Per Pack Fee listed in the Pharmaceutical Schedule (which is pro-rated if less than the full pack of the relevant Pharmaceutical, as listed in the Pharmaceutical Schedule, is Supplied) HF = the Handling Fee for the Pharmaceutical, which is $1.01 HFM = the Handling Fee Multiplier for the Pharmaceutical, which is 26.50 GST = 1.15 (such other amount as correctly reflects the GST rate on the date of Supply) CoP = the Co-payment payable by the Service User (if any)
9.3 Subject to clause 9.4, if "R" is a negative number:
(a) that number will be treated as a positive amount; and
(b) the DHB will be entitled to recover that amount from the Provider (including by way of set-off).
9.4 The DHB will not recover (nor be entitled to recover) the amount "R" if the Supply of the Pharmaceutical is a Negative A3 or J3 Transaction.
1. Background and service objectives
